Your browser doesn't support javascript.
loading
Inhibition of colony stimulating factor 1 receptor corrects maternal inflammation-induced microglial and synaptic dysfunction and behavioral abnormalities.
Ikezu, Seiko; Yeh, Hana; Delpech, Jean-Christophe; Woodbury, Maya E; Van Enoo, Alicia A; Ruan, Zhi; Sivakumaran, Sudhir; You, Yang; Holland, Carl; Guillamon-Vivancos, Teresa; Yoshii-Kitahara, Asuka; Botros, Mina B; Madore, Charlotte; Chao, Pin-Hao; Desani, Ankita; Manimaran, Solaiappan; Kalavai, Srinidhi Venkatesan; Johnson, W Evan; Butovsky, Oleg; Medalla, Maria; Luebke, Jennifer I; Ikezu, Tsuneya.
  • Ikezu S; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA. sikezu@bu.edu.
  • Yeh H; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Delpech JC; Graduate Program in Neuroscience, Boston University, Boston, MA, USA.
  • Woodbury ME; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Van Enoo AA; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Ruan Z; Graduate Program in Neuroscience, Boston University, Boston, MA, USA.
  • Sivakumaran S; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • You Y; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Holland C; Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
  • Guillamon-Vivancos T; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Yoshii-Kitahara A; Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
  • Botros MB; Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
  • Madore C; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Chao PH; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Desani A; Ann Romney Center for Neurologic Diseases, Department of Neurology and Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Manimaran S; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Kalavai SV; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Johnson WE; Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
  • Butovsky O; Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Medalla M; Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
  • Luebke JI; Ann Romney Center for Neurologic Diseases, Department of Neurology and Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Ikezu T; Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Mol Psychiatry ; 26(6): 1808-1831, 2021 06.
Article en En | MEDLINE | ID: mdl-32071385
ABSTRACT
Maternal immune activation (MIA) disrupts the central innate immune system during a critical neurodevelopmental period. Microglia are primary innate immune cells in the brain although their direct influence on the MIA phenotype is largely unknown. Here we show that MIA alters microglial gene expression with upregulation of cellular protrusion/neuritogenic pathways, concurrently causing repetitive behavior, social deficits, and synaptic dysfunction to layer V intrinsically bursting pyramidal neurons in the prefrontal cortex of mice. MIA increases plastic dendritic spines of the intrinsically bursting neurons and their interaction with hyper-ramified microglia. Treating MIA offspring by colony stimulating factor 1 receptor inhibitors induces depletion and repopulation of microglia, and corrects protein expression of the newly identified MIA-associated neuritogenic molecules in microglia, which coalesces with correction of MIA-associated synaptic, neurophysiological, and behavioral abnormalities. Our study demonstrates that maternal immune insults perturb microglial phenotypes and influence neuronal functions throughout adulthood, and reveals a potent effect of colony stimulating factor 1 receptor inhibitors on the correction of MIA-associated microglial, synaptic, and neurobehavioral dysfunctions.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Efectos Tardíos de la Exposición Prenatal / Microglía Tipo de estudio: Prognostic_studies Límite: Animals / Pregnancy Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Efectos Tardíos de la Exposición Prenatal / Microglía Tipo de estudio: Prognostic_studies Límite: Animals / Pregnancy Idioma: En Año: 2021 Tipo del documento: Article